KRAS and neoplasm: The clinical data metrics that showed statistically significant associations to the HDSCA data were KRAS mutation status, location of tumor in colon, tumor stage, size of metastasis, location of metastasis, synchronous disease status, and if the patient had received neoadjuvant chemotherapy.